Tianjin Zhongxin Pharmaceutical Group Corp Ltd (600329) — Net Asset Quality Index
Tianjin Zhongxin Pharmaceutical Group Corp Ltd (600329) has a Net Asset Quality Index of 77.9% as of September 2025. This metric measures the proportion of total assets financed by shareholders' equity — total assets of CN¥11.59 Billion minus total liabilities of CN¥2.56 Billion yields net assets of CN¥9.02 Billion. A higher index indicates a stronger, lower-leverage balance sheet. Check asset resilience ratio of Tianjin Zhongxin Pharmaceutical Group Co to evaluate the company's liquid asset resilience ratio.
Quality Index
Net Assets
Total Assets
Total Liabilities
Tianjin Zhongxin Pharmaceutical Group Corp Ltd Net Asset Quality Index Over Time (1998–2024)
This chart shows how Tianjin Zhongxin Pharmaceutical Group Corp Ltd's Net Asset Quality Index has evolved across 27 annual periods from 1998 to 2024. As of September 2025, the index stands at 77.9%, representing net assets of CN¥9.02 Billion against total assets of CN¥11.59 Billion CNY. See how liquid is Tianjin Zhongxin Pharmaceutical Group Co's working capital to evaluate short-term liquidity relative to the company's equity base.
Annual Net Asset Quality Index for Tianjin Zhongxin Pharmaceutical Group Corp Ltd (1998–2024)
The table below presents the year-by-year Net Asset Quality Index for Tianjin Zhongxin Pharmaceutical Group Corp Ltd from 1998 to 2024, covering 27 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For market capitalisation and the full company profile, see market cap of Tianjin Zhongxin Pharmaceutical Group Co.
| Year | Quality Index | Net Assets (CNY) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2024 | 72.9% | CN¥7.85 Billion | CN¥10.77 Billion | CN¥2.92 Billion | ▲ +7.9 pp |
| 2023 | 65.0% | CN¥6.65 Billion | CN¥10.23 Billion | CN¥3.58 Billion | ▲ +0.5 pp |
| 2022 | 64.5% | CN¥6.55 Billion | CN¥10.16 Billion | CN¥3.61 Billion | ▼ -7.3 pp |
| 2021 | 71.8% | CN¥6.51 Billion | CN¥9.07 Billion | CN¥2.55 Billion | ▲ +0.0 pp |
| 2020 | 71.8% | CN¥5.95 Billion | CN¥8.28 Billion | CN¥2.33 Billion | ▲ +1.4 pp |
| 2019 | 70.4% | CN¥5.52 Billion | CN¥7.84 Billion | CN¥2.32 Billion | ▼ -0.7 pp |
| 2018 | 71.1% | CN¥5.05 Billion | CN¥7.11 Billion | CN¥2.05 Billion | ▲ +1.3 pp |
| 2017 | 69.9% | CN¥4.63 Billion | CN¥6.62 Billion | CN¥2.00 Billion | ▲ +2.2 pp |
| 2016 | 67.6% | CN¥4.30 Billion | CN¥6.36 Billion | CN¥2.06 Billion | ▼ 0.0 pp |
| 2015 | 67.6% | CN¥4.11 Billion | CN¥6.07 Billion | CN¥1.96 Billion | ▲ +13.4 pp |
| 2014 | 54.2% | CN¥2.95 Billion | CN¥5.44 Billion | CN¥2.49 Billion | ▲ +5.3 pp |
| 2013 | 48.9% | CN¥2.57 Billion | CN¥5.26 Billion | CN¥2.69 Billion | ▼ -2.6 pp |
| 2012 | 51.6% | CN¥2.28 Billion | CN¥4.42 Billion | CN¥2.14 Billion | ▼ -1.7 pp |
| 2011 | 53.2% | CN¥2.21 Billion | CN¥4.14 Billion | CN¥1.94 Billion | ▼ -1.2 pp |
| 2010 | 54.4% | CN¥2.09 Billion | CN¥3.84 Billion | CN¥1.75 Billion | ▲ +5.6 pp |
| 2009 | 48.8% | CN¥1.79 Billion | CN¥3.67 Billion | CN¥1.88 Billion | ▲ +6.0 pp |
| 2008 | 42.7% | CN¥1.47 Billion | CN¥3.44 Billion | CN¥1.97 Billion | ▲ +4.0 pp |
| 2007 | 38.7% | CN¥1.35 Billion | CN¥3.47 Billion | CN¥2.13 Billion | ▼ -1.4 pp |
| 2006 | 40.2% | CN¥1.41 Billion | CN¥3.51 Billion | CN¥2.10 Billion | ▼ -7.9 pp |
| 2005 | 48.1% | CN¥1.95 Billion | CN¥4.06 Billion | CN¥2.11 Billion | ▲ +0.1 pp |
| 2004 | 48.0% | CN¥1.88 Billion | CN¥3.91 Billion | CN¥2.04 Billion | ▼ -0.4 pp |
| 2003 | 48.4% | CN¥1.84 Billion | CN¥3.80 Billion | CN¥1.96 Billion | ▼ -7.7 pp |
| 2002 | 56.2% | CN¥1.69 Billion | CN¥3.01 Billion | CN¥1.32 Billion | ▼ -0.5 pp |
| 2001 | 56.7% | CN¥1.54 Billion | CN¥2.72 Billion | CN¥1.18 Billion | ▲ +11.1 pp |
| 2000 | 45.6% | CN¥1.15 Billion | CN¥2.53 Billion | CN¥1.38 Billion | ▼ -33.3 pp |
| 1999 | 78.8% | CN¥1.14 Billion | CN¥1.45 Billion | CN¥306.96 Million | ▼ -3.9 pp |
| 1998 | 82.8% | CN¥1.06 Billion | CN¥1.28 Billion | CN¥220.53 Million | — |